Recall Register

Drug recall: Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74…

Class III FDA enforcement event 80834. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Defective Delivery System: Water ingress through the lower water cup sensor of the device.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

United Therapeutics Corp. started this drug recall on 14 Aug 2018. The firm address in the FDA record is in Durham, NC. FDA put the recall in Class III. FDA event 80834 has 1 product record. The first FDA enforcement report date is 19 Sep 2018. The record gives the status Terminated, with the termination date 30 Oct 2019. 128 of the 367 drug events that started in 2018 have more product records. The median drug event of 2018 has 1 product record. The openFDA file has 367 drug events that started in 2018 and 343 that started in 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

IL, PA

Recalling firm

United Therapeutics Corp., Durham, NC.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 80834: product records
Recall numberProductQuantityClassStatusReport date
D-1188-2018Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 277092801 devicesClass IIITerminated19 Sep 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2018
367
Share of these events in Class III
29%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
3

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 80834. https://recallregister.com/fda/iii/80834/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: IL, PA
What quantity of product is in FDA event 80834?
The FDA record gives this quantity: 2801 devices
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2018 have the same class?
29% of the 367 drug events that started in 2018 are in Class III.